Section13:References

From Assay Guidance Wiki

1. Copeland RA. Mechanistic Considerations in High-Throughput Screening. Analytical Biochemistry 2003, v320, pgs 1-12.
2. Copeland RA. Enzymes: A Practical Introduction to Structure, Mechanism, and Data Analysis, second edition. 2000, Wiley, New York.
3. Copeland RA. Evaluation of Enzyme Inhibitors in Drug Discovery: A Guide for Medicinal Chemists and Pharmacologists. 2005, Wiley, New York.
4. Copeland RA, Pompliano DL, Meek TD. Drug-Target Residence Time and Its Implications for Lead Optimization. Nature Reviews Drug Discovery 2006, v5, pgs 730-739.
5. Feng, B. Y.; Simeonov, A.; Jadhav, A.; Babaoglu, K.; Inglese, J.; Shoichet, B. K.; Austin, C. P., A high-throughput screen for aggregation-based inhibition in a large compound library. J Med Chem 2007, 50, 2385-90.
6. Fehrst A. Structure and Mechanism in Protein Science: A Guide to Enzyme Catalysis and Protein Folding. 1999, W.H. Freeman, New York.
7. Kenakin TP. A Pharmacology Primer: Theory, Application, and Methods. 2004, Elsevier, San Diego.
8. Robertson JG. Mechanistic Basis of Enzyme-Targeted Drugs. Biochemistry 2006, v44, pgs 5561-5571.
9. Segal IH. Enzyme Kinetics: Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems. 1975, Wiley, New York.
10. Shoichet BK. Screening in a Spirit Haunted World. Drug Discovery Today 2006, v11, pgs 607-615.
11. Swinney DC. Biochemical Mechanisms of Drug Action: What Does It Take For Success? Nature Reviews Drug Discovery 2004, v3, pgs 801-808.
12. Swinney DC. Biochemical Mechanisms of New Molecular Entities (NMEs) Approved by United States FDA During 2001-2004: Mechanisms Leading to Optimal Efficacy and Safety. Current Topics in Medicinal Chemistry 2006, v6, pgs 461-478.